Our findings highlight an adaptive mechanism whereby the lack of ERO1 in breast tumour cells converges on the PERK pathway of the UPR and, by attenuating protein translation, limits the proteotoxicity. The gene discussed is EIF2AK3; the disease is breast neoplasm.